Security key
19188J409
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)
CUSIP: 19188J409
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 13,831,528
- Total 13F shares
- 770,490
- Share change
- +53,208
- Total reported value
- $754,323
- Price per share
- $0.98
- Number of holders
- 26
- Value change
- +$52,087
- Number of buys
- 8
- Number of sells
- 10
Report period
Q4 2025
Institutions
26
Top holders
10
COCP full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Cocrystal Pharma, Inc. SEC filings
Cocrystal Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19188J409
Recent filing periods:
Top shareholders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Et al Phillip Frost MD |
13D/G
|
Phillip Frost, M.D. |
18%
|
2,462,012
|
$3,078,992 | +$1,349,571 | 28 Oct 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
268,080
|
$335,100 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.92%
|
127,928
|
$159,910 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
73,929
|
$92,428 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.53%
|
73,746
|
$92,183 | — | 30 Sep 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.23%
|
31,886
|
$39,858 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
21,044
|
$26,305 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
20,543
|
$25,679 | — | 30 Sep 2025 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.09%
|
12,611
|
$15,764 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
11,921
|
$14,901 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
9,092
|
$11,365 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
5,863
|
$7,330 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
3,298
|
$4,122 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
1,812
|
$2,266 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
1,053
|
$1,316 | — | 30 Sep 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.01%
|
817
|
$1,021 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
571
|
$714 | — | 30 Sep 2025 | |
| Clean Yield Group |
13F
|
Company |
0%
|
418
|
$523 | — | 30 Sep 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
237
|
$297 | — | 30 Sep 2025 | |
| NVWM, LLC |
13F
|
Company |
0%
|
84
|
$105 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
34
|
$43 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
16
|
$20 | — | 30 Sep 2025 |
Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q4 2025
As of 31 Dec 2025,
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
770,490 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., T3 Companies, LLC, DRW Securities, LLC, NEUBERGER BERMAN GROUP LLC, STATE STREET CORP, XTX Topco Ltd, and TWO SIGMA SECURITIES, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
21
Q4 2025 holders
26
Holder diff
5
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.